116 results

Mathew Martoma: a former SAC portfolio manager, is charged with using confidential information provided by two doctors involved in clinical trials to trade in drug firms Elan and Wyeth, which is now owned by Pfizer. Photograph: Reuters

A trial starting this week over what US prosecutors call the most lucrative insider trading scheme ever will likely delve into the trading activity of(...)

Perrigo chief executive Joe Papa.

The curtain came down last night on Elan’s existence as an independent company. The acquisition of the business founded in 1969 by Don Panoz to commer(...)

The Elan Corporation plant in Athlone, Co Westmeath. Photograph: John Cogill/Bloomberg News

The Commercial Court has approved the €6.27 billion acquisition of the Elan pharmaceutical group by US firm Perrigo. Mr Justice Peter Kelly made the r(...)

Following the completion of the acquisition of Elan by Perrigo, Elan will no longer trade on the Irish Stock Exchange. (Photographer:John Cogill/Bloomberg)

The High Court has today approved Perrigo’s proposed acquisition of Irish pharmaceutical company, Elan, paving the way for the deal to be finalised.Th(...)

US generic drugmaker Perrigo is to pay $8.6 billion (€ 6.48 billion) for Elan. Photographer:John Cogill/Bloomberg News.

Shareholders in Elan overwhelmingly voted in favour of the proposed acquisition of the pharmaceutical group by the US company Perrigo this morning. At(...)

Elan put itself up for sale in June after rejecting a number of hostile bids from private equity firm Royal Pharma. Photograph:John Cogill/Bloomberg News.

Biotech company Elan reported a $13.8 million loss in the third quarter as costs associated with the proposed takeover by pharmaceuticals firm Perr(...)

Departing companies

The Irish Stock Exchange has been in existence since 1793, but for how much longer? That question is again raised by the growing number of departur(...)

Shareholders in biotech company Elan got an update on their opportunity to vote on Michigan-based pharmaceuticals group Perrigo’s proposed acquisition of the Irish company on November 18th in Dublin. Photographer: John Cogill/Bloomberg News

Investors worries that even a temporary US government shutdown could put a damper on an already weak economic recovery hung over global markets yester(...)

Perrigo is set to acquire Elan in a $8.6 billion (€ 6.48 billion) deal

Shareholders in biotech company Elan will get an opportunity to vote on Michigan-based pharmaceuticals group Perrigo’s proposed acquisition of the Iri(...)

Alkermes chief executive Richard Pops: “We are interested in depression, addiction, schizophrenia and pain, the big ones. Why? Because these are where governments are spending all the money.”  Photograph: Dara Mac Dónaill

When Alkermes acquired Elan’s drug technology business in Athlone in a $960 million buyout two years ago, everyone knew what it was after – or at leas(...)

  • « First
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
  • Last »